Commercial Mastitis Vaccines - Effects on Mastitis Rates and Somatic Cell Counts in Saanen Goats

Authors

  • Gokhan Bozkurt Burdur Mehmet Akif Ersoy University, Burdur, Turkey. https://orcid.org/0000-0003-1837-4492
  • Ibrahım Tasal Burdur Mehmet Akif Ersoy University, Burdur, Turkey.

DOI:

https://doi.org/10.22456/1679-9216.131112

Abstract

Background: Staphylococcus spp. are the most frequently isolated microorganisms in mastitis cases of small ruminants. The virulence factors of Staphylococcus spp. are critical in the treatment. Therefore, preventive medicine and mastitis control programs, especially herd vaccinations are of great importance in the prevention of mastitis. However, it is not always easy to obtain these vaccines under field conditions. This study, it was aimed to compare the effects of different commercial Staphylococcus spp. vaccines licensed for bovines and species-specific mastitis vaccines on mastitis rates and somatic cell count on Saanen goats on field conditions.

Materials, Methods & Results: The animal material consisted of 115 (230 udder halves) nulliparous Saanen goats. Goats were randomly grouped as bovine vaccine 1 (BV1, n = 58), bovine vaccine 2 (BV2, n = 58), small ruminant vaccine (SRV, n = 56), and control (n = 56). Vaccines were administered to goats in 2 doses according to the label regimen. First milk samples were collected between 0-5 days in milk (DIM) for microbiological analysis and 25-35 DIM for SCC. The other milk samples were collected at 25-35 (1st month) DIM, 60-65 (2nd month) DIM, 85-95 (3rd month) DIM, 115-125 (4th month) DIM, 145-155 (5th month) DIM for microbiological analysis and SCC. Non-aureus staphylococci (NAS) and S. aureus were the most frequently isolated microorganism. It was found that the total mastitis rate decreased in vaccine groups compared to the control group. A significant difference was found only in the BV2 and SRV groups. The significant difference in Staphylococcus aureus infection was found only in the SRV group. Mastitis vaccines used in this study decreased the NAS mastitis rate, but no significant difference was observed. It was found that the clinical mastitis incidence decreased in all vaccine groups compared to the control group, and a significant difference was found between the BV2 and SRV groups compared to the control group (P < 0.05). Somatic cell count was lower in the SRV and BV2 groups compared to the control group (P < 0.05).

Discussion: In this study, compatible with the previous reports NAS and Staphylococcus aureus were the most frequently isolated microorganism. The diversity of virulence factors of Staphylococcus spp. also plays an important role in its high incidence. In some countries, mastitis vaccines used in cows are also administered to small ruminants for reducing infection rates. Similarly, in this study, it was found that the mastitis rate decreased in all vaccine groups compared to the control group. A significant difference was found only in the BV2 and SRV groups. It is thought that the reason for the statistical difference may be due to the biofilm antigen in the BV2 and SRV. In addition, J5 strain in the BV2 is estimated to be effective in reducing the prevalence of gram-negative mastitis. It was observed that the infection rates decreased in the vaccine groups, especially due to S. aureus and NAS. Spontaneous treatment rates were very close to each other between the groups. The reason for the high rate of spontaneous treatment in this study can be explained by the fact that the animals were young and in their 1st lactation. SCC was lower in all vaccine groups compared to the control group. This situation is associated with the decrease in infection rates related to the use of vaccines. It was observed that SCC was lower in the vaccine groups. In addition, SCC was found to be lower in this study compared to similar studies. However, it is evident that the use of species-specific vaccines in the SRV group significantly reduced the rates of total S. aureus mastitis, subclinical NAS mastitis, and new infections by NAS compared to other vaccines. Furthermore, the species-specific vaccine significantly increased the rate of spontaneous treatment for S. aureus mastitis.

Keywords: field condition, mastitis, milk, Non-aureus staphylococci, small ruminant, vaccine.

Downloads

Download data is not yet available.

References

Albenzio M., Taibi L., Muscio A. & Sevi A. 2002. Prevalence and etiology of subclinical mastitis in intensively managed flocs and related changes in the yield and quality of ewe milk. Small Ruminant Research. 43(3): 219-226. DOI: https://doi.org/10.1016/S0921-4488(02)00022-6

Bergonier D., Cremoux R.D., Rupp R., Lagriffoul G & Berthelot X. 2003. Mastitis of dairy small ruminants. Veterinary Research. 34(5): 689-716. DOI: https://doi.org/10.1051/vetres:2003030

Chang B.S., Moon J.S., Kang H.M., Kim Y.I., Lee H.K., Kim J.D., Lee B.S., Koo H.C. & Park Y.H. 2008. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle. Vaccine. 26(17): 2081-2091. DOI: https://doi.org/10.1016/j.vaccine.2008.02.043

Contreras A., Corrales J.C., Sierra D. & Marco J. 1995. Prevalence and etiology of non-clinical intramammary infection in Murciano-Granadina goats. Small Ruminant Research. 17(1): 71-78. DOI: https://doi.org/10.1016/0921-4488(95)00651-Z

Cucarella C., Tormo M.A., Ubeda C., Trotonda M.P., Monzon M., Peris C., Amorena B., Lasa I. & Penades J.R. 2004. Role of biofilm-associated protein Bap in the pathogenesis of bovine Staphylococcus aureus. Infection and Immunity. 72(4): 2177-2185. DOI: https://doi.org/10.1128/IAI.72.4.2177-2185.2004

Deinhofer M. & Pernthaner A. 1995. Staphylococcus spp. as mastitis-related pathogens in goat milk. Veterinary Microbiology. 43(2-3): 161-166. DOI: https://doi.org/10.1016/0378-1135(95)92532-G

Diaz J.R., Romero G., Muelas R., Alejandro M. & Peris C. 2012. Effect of intramammary infection on milk electrical conductivity in Murciano-Granadina goats. Journal of Dairy Science. 95(2): 718-726. DOI: https://doi.org/10.3168/jds.2011-4698

Dogruer G., Saribay M.K., Aslantas O., Kirecci E., ErgUn Y., Ulku A. & Demir C. 2016. The prevalance, etiology and antimicrobial susceptibility of the microorganisms in subclinical mastitis in goats. Veterinary Sciences and Practices. 11(2): 138-145. DOI: https://doi.org/10.17094/avbd.25211

Dore S., Liciardi M., Amatiste S., Bergagna S., Bolzoni G., Caligiuri V., Cerrone A., Farina G., Montagna C.O., Saletti M.A., Scatassa M.L., Sotgiu G. & Cannas E.A. 2016. Survey on small ruminant bacterial mastitis in Italy, 2013-2014. Small Ruminant Research. 141: 91-93. DOI: https://doi.org/10.1016/j.smallrumres.2016.07.010

Felipe V., Morgante C.A., Somale P.S., Varroni F., Zingaretti M.L., Bachetti R.A., Correa S.G. & Porporatto C. 2007. Evaluation of the biofilm forming ability and its associated genes in Staphylococcus species isolates from bovine mastitis in Argentinean. Microbial Pathogenesis. 104: 278-286. DOI: https://doi.org/10.1016/j.micpath.2017.01.047

Fernandez J.A., García Carrero F., Delgado Rodríguez C. & Sanz Franco M.A 2018. Efficacy of vaccination against biofilm-producing Staphylococci as a preventive measure against subclinical mastitis in Lacaune and Manchega sheep in Spain Rodríguez. In: International Bovine Mastitis Congress (Milano-Italy).

Fthenakis G.C. 1994. Prevalence and etiology of subclinical mastitis in ewes of southern Greece. Small Ruminant Research. 13(3): 293-300. DOI: https://doi.org/10.1016/0921-4488(94)90078-7

Gelasakis A.I., Angelidis A.S., Giannakou R., Filioussis G., Kalamaki M.S. & Arsenos G. 2016. Bacterial subclinical mastitis and its effect on milk yield in low-input dairy goat herds. Journal of Dairy Science. 99(5): 1-11. DOI: https://doi.org/10.3168/jds.2015-10694

Hogan J. & Smith K.L. 2003. Coliform mastitis. Veterinary Research. 34: 507-519. DOI: https://doi.org/10.1051/vetres:2003022

Hristov K., Popova T., Pepovich R. & Nikolov B. 2016. Characterization of microbial causative agents of subclinical mastitis in goats in Bulgaria. International Journal of Current Microbiology and Applied Sciences. 5(8): 316-323. DOI: https://doi.org/10.20546/ijcmas.2016.508.034

International Dairy Federation. 1981. Laboratory Methods for Use in Mastitis Work. Brussels, Belgium. (Document no: 132).

International Dairy Federation. 1995. Enumeration of somatic cells. Brussels, Belgium. (Standard No. 148A. FIL-IDF).

Ilhan Z., Tasal I., Sagcan S. & Solmaz H. 2011. Isolation of aerobic bacteria from goat milk with subclinical mastitis. Van Veterinary Journal. 22(2): 89-91.

Kahinda C.T.M. 2022. Mastitis in Dairy Cattle, Sheep and Goats. In: Dego O.K. (Ed). Mastitis in Small Ruminants. London: IntechOpen, pp.87-114.

Kautz F.M., Nickerson S.C. & Ely L.O. 2014. Use of a staphylococcal vaccine to reduce prevalence of mastitis and lower somatic cell counts in a registered Saanen dairy goat herd. Research in Veterinary Science. 97(1): 18-19. DOI: https://doi.org/10.1016/j.rvsc.2014.04.013

Keskin A., Seyrek-Intas K., Tek H.B., Tuna B., Yılmazbas G., Ozakin C. & Ertas S. 2007. Efficiency of polyvalent mastitis vaccine in lactating dairy cows. Journal of Biological and Environmental Sciences. 1(2): 87-92.

Leitner G., Yadlin N., Lubashevsy E., Ezra E., Glickman A., Chaffer M., Winkler M., Sarana A. & Trainin Z. 2003. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. field trial. Veterinary Immunology and Immunopathology. 93(3-4): 153-158. DOI: https://doi.org/10.1016/S0165-2427(03)00062-X

Leitner G., Lubashevsky E., Glickman A., Winkler M., Sarana A. & Trainin Z. 2003. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows I. Challenge trials. Veterinary Immunology and Immunopathology. 93(1-2): 31-38. DOI: https://doi.org/10.1016/S0165-2427(03)00051-5

Mahlangu P., Maina N. & Kagira J. 2018. Prevalence, risk factors, and antibiogram of bacteria isolated from milk of goats with subclinical mastitis in Thika East Subcounty, Kenya. Journal of Veterinary Medicine. 2018: ID 3801479 DOI: 10.1155/2018/3801479 DOI: https://doi.org/10.1155/2018/3801479

Marogna G., Pilo C., Vidili A., Tola S., Schianchi G. & Leori S.G. 2012. Comparison of clinical findings, microbiological result, and farming parameters in goats herds affected by recurrent infectious mastitis. Small Ruminant Research. 102(1): 74-83. DOI: https://doi.org/10.1016/j.smallrumres.2011.08.013

Mella A., Ulloa F., Valdes I., Olivares N., Ceballos A. & Kruze J. 2017. Evaluation of a new vaccine against Staphylococcus aureus mastitis in dairy herds of southern Chile I challenge trial. Australian Journal Veterinary Science. 49(3): 149-160. DOI: https://doi.org/10.4067/S0719-81322017000300149

Middleton J.R., Luby C.D. & Adams D.S. 2009. Efficacy of vaccination against staphylococcal mastitis. A review and new data. Veterinary Microbiology. 134(1-2): 192-198. DOI: https://doi.org/10.1016/j.vetmic.2008.09.053

National Mastitis Council. 2017. Laboratory Handbook on Bovine Mastitis. National Mastitis Council Inc. (New Prague, USA). 148p.

Nordhaug M.L., Nesse L.L., Norcross M.L. & Gudding R. 1994. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters. Journal of Dairy Science. 77(5): 1267-1275. DOI: https://doi.org/10.3168/jds.S0022-0302(94)77066-1

Paape M.J., Capuco A.V., Contreras A. & Marco J.C. 2001. Milk somatic cells and lactation in small ruminants. Journal of Dairy Science. (84): 237-244. DOI: https://doi.org/10.3168/jds.S0022-0302(01)70223-8

Pereira U.P., Oliveira D.G., Mesquita L.R., Costa G.M. & Pereira L.J. 2011. Efficacy of Staphylococcus aureus vaccines for bovine mastitis. A systematic review. Veterinary Microbiology. 148(2-4): 117-124. DOI: https://doi.org/10.1016/j.vetmic.2010.10.003

Persson Y., Jarnberg A., Humblot P. & Nyman A. 2015. Associations between Staphylococcus aureus intramammary infections and somatic cell counts in dairy goat herds. Small Ruminant Research. 133: 62-66. DOI: https://doi.org/10.1016/j.smallrumres.2015.11.003

Pir Yagcı I. & Kaymaz M. 2006. Detection of subclinical mastitis by clinical, microbiological and biochemical methods in sheep. Ankara Üniversitesi Veteriner Fakültesi Dergisi. 53: 31-35.

Rovai M., Caja G., Salama A.A.K., Jubert A., Lázaro B., Lázaro M. & Leitner G. 2014. Identifying the major bacteria causing intramammary infections in individual milk samples of sheep and goats using traditional bacteria culturing and real-time polymerase chain reaction. Journal of Dairy Science. 97(9): 5393-5400. DOI: https://doi.org/10.3168/jds.2014-7988

Ruiz P., Barragan I., Sesena S. & Palop M.L. 2016. Is staphylococci population from milk of healthy goats safe? International Journal of Food Microbiology. 238: 146-152. DOI: https://doi.org/10.1016/j.ijfoodmicro.2016.08.033

Schukken Y.H., Bronzo V., Locatelli C., Pollera C., Rota N., Casula A., Testa F., Scaccabarozzi L., March R., Zalduendo D., Guix R. & Moroni P. 2014. Efficacy of vaccination on Staphylococcus aureus and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds. Journal of Dairy Science. 97(8): 5250-5264. DOI: https://doi.org/10.3168/jds.2014-8008

Tenhagen B.A., Edinger D., Baumgartner B., Kalbe P, Kluender G. & Heuwieser W. 2001. Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers. Journal of Veterinary Medicine. 48(10): 601-607. DOI: https://doi.org/10.1046/j.1439-0442.2001.00397.x

Vasileiou N.G.C., Chatzopoulos D.C., Cripps P.J., Ioannidi K.S., Gougoulis D.A., Chouzouris T.M. & Fthenakis G.C. 2019. Evaluation of efficacy of a biofilm-embedded bacteria-based vaccine against staphylococcal mastitis in sheep-A randomized, placebo controlled field study. Journal of Dairy Science. 102(10): 9328-9344. DOI: https://doi.org/10.3168/jds.2019-16287

Vasileiou N.G.C., Chatzopoulos D.C., Gougoulis D.A., Sarrou S., Katsafadou A.I., Spyrou V., Mavrogianni V.S., Petinaki E. & Fthenakis G.C. 2018. Slime-producing staphylococci as causal agents of subclinical mastitis in sheep. Veterinary Microbiology. 224: 93-99. DOI: https://doi.org/10.1016/j.vetmic.2018.08.022

Watson D.L., McColl M.L. & Davies H.I. 1996. Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessments. Australian Veterinary Journal. 74(6): 447-450. DOI: https://doi.org/10.1111/j.1751-0813.1996.tb07567.x

White E.C. & Hinckley L.S. 1999. Prevalence of mastitis pathogens in goat milk. Small Ruminant Research. 33(2): 117-121. DOI: https://doi.org/10.1016/S0921-4488(99)00013-9

Additional Files

Published

2023-07-24

How to Cite

Bozkurt, G., & Tasal, I. (2023). Commercial Mastitis Vaccines - Effects on Mastitis Rates and Somatic Cell Counts in Saanen Goats . Acta Scientiae Veterinariae, 51. https://doi.org/10.22456/1679-9216.131112

Issue

Section

Articles